ZyVersa Therapeutics Statistics
Total Valuation
ZVSA has a market cap or net worth of 1.25 million. The enterprise value is 1.18 million.
| Market Cap | 1.25M |
| Enterprise Value | 1.18M |
Important Dates
The last earnings date was Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ZVSA has 8.10 million shares outstanding. The number of shares has increased by 516.02% in one year.
| Current Share Class | 8.10M |
| Shares Outstanding | 8.10M |
| Shares Change (YoY) | +516.02% |
| Shares Change (QoQ) | +54.95% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 0.79% |
| Float | 8.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.20 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.14 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
| Current Ratio | 0.04 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -14.91 |
Financial Efficiency
Return on equity (ROE) is -112.65% and return on invested capital (ROIC) is -65.77%.
| Return on Equity (ROE) | -112.65% |
| Return on Assets (ROA) | -24.75% |
| Return on Invested Capital (ROIC) | -65.77% |
| Return on Capital Employed (ROCE) | -111.41% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.18M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2,962 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.31% in the last 52 weeks. The beta is 0.74, so ZVSA's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | -94.31% |
| 50-Day Moving Average | 0.44 |
| 200-Day Moving Average | 0.88 |
| Relative Strength Index (RSI) | 33.11 |
| Average Volume (20 Days) | 152,514 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.10 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.74M |
| Pretax Income | -8.29M |
| Net Income | -8.29M |
| EBITDA | -7.74M |
| EBIT | -7.74M |
| Earnings Per Share (EPS) | -3.04 |
Balance Sheet
The company has 72,086 in cash and n/a in debt, giving a net cash position of 72,086 or 0.01 per share.
| Cash & Cash Equivalents | 72,086 |
| Total Debt | n/a |
| Net Cash | 72,086 |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 6.10M |
| Book Value Per Share | 1.25 |
| Working Capital | -12.14M |
Cash Flow
| Operating Cash Flow | -5.16M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ZVSA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -516.02% |
| Shareholder Yield | -516.02% |
| Earnings Yield | -663.12% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 26, 2024. It was a reverse split with a ratio of 0.1.
| Last Split Date | Apr 26, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |